SureClinical Announces Complimentary eClinical Applications for New COVID-19 Clinical Trials

Seeking the Fastest Path to Global Eradication of COVID-19 Virus   Reno, Nevada, April 15 2020 – SureClinical, the premier provider of FDA and EU compliance validated eClinical cloud applications today announced a complimentary COVID-19 eClinical application program to support Clinical Research Organizations and Sponsors who are developing COVID-19 vaccines and treatments.  With four active global […]

Read More

ImageDx: NASH – A New Generation of Quantitative NASH Data

Traditional NAFLD Activity Scoring Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of liver dysfunction, with some estimates suggesting up to 30% of the general population as being affected (1). NAFLD, while mainly asymptomatic, can progress to non-alcoholic steatohepatitis (NASH) in a portion of individuals. NASH is characterized by multiple pathologic […]

Read More

Neuroservices-Alliance biggest takeaways and lessons learned from projects and collaborations they’ve experienced throughout the year

So far, 2019 has been the year of building strong relationships between our members and reinforcing our ability to be a one-stop-shop CNS CRO thanks to our complimentary CNS platforms and our strong ensemble of experts. We participated in many of the main Neuroscience events worldwide and still have more to come (BIO Japan, Neuroscience […]

Read More

Pharma Formulation Services Blog Series Part 2: Respect the Chemistry

Sometimes you have no choice. “You can have any color you want ‘so long as it is black.’” “Ice cream sold here: vanilla.” You get the idea. So it is with formulation. A substance will demand certain treatment. An API with the solubility of brick dust requires a dosage form to enhance solubility. An API […]

Read More

Pharma Formulation Services Blog Series Part 1: Solving a Problem

The Role of Pharmaceutical Formulation Development Unlike other drug development activities, which are checkbox activities to meet FDA requirements, a good formulation solves a problem: “I’ve got this new molecule with fantastic in vitro activity, but how do I dose it? Will it be stable? Can I measure this? Is this suitable for the given […]

Read More

Long & Short of USP Guidelines for EL Testing by Avomeen

Sources of Impurities in Pharmaceutical Products In the development of a drug product, careful consideration needs to be given to impurities that may originate from manufacturing equipment, process components, and packaging materials. The majority of such impurities are common chemical additives used to improve the physicochemical properties of a wide range of plastic materials. Suppliers […]

Read More

Image Analysis: Enabling Data Powered Pathology by Reveal Bioscience

Image Analysis: Enabling Data Powered Pathology The rise of whole slide imaging has enabled a variety of computational tools to facilitate the extraction of quantitative data from tissue samples on microscope slides. The practice of using computational algorithms to collect these data from whole slide images is known as “image analysis”. Image analysis has already […]

Read More